| RYWAX | VEXRX | RYWAX / VEXRX | |
| Total Expense Ratio | 1.56 | 0.28 | 557% |
| Annual Report Gross Expense Ratio | 1.61 | 0.28 | 575% |
| Fund Existence | 23 years | 25 years | - |
| Gain YTD | 25.218 | 18.596 | 136% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 50000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.97M | 22.1B | 0% |
| Annual Yield % from dividends | 0.00 | 0.49 | - |
| Returns for 1 year | 29.13 | 17.56 | 166% |
| Returns for 3 years | 46.08 | 34.85 | 132% |
| Returns for 5 years | -22.93 | -5.23 | 439% |
| Returns for 10 years | 18.91 | 55.04 | 34% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BHSRX | 63.40 | 0.82 | +1.31% |
| BlackRock Health Sciences Opps R | |||
| GMWEX | 13.76 | 0.13 | +0.97% |
| GuideMark® World ex-US Service | |||
| TASMX | 32.96 | 0.23 | +0.70% |
| Transamerica Small/Mid Cap Value R6 | |||
| MDFOX | 6.82 | 0.03 | +0.44% |
| BlackRock Large Cap Focus Growth Inv A | |||
| CUSRX | 14.95 | 0.03 | +0.20% |
| Cullen Small Cap Value Retail | |||